- Login
- Register & Subscribe
- Language: EN FR DE
Finance, Grants, Deals
Novacta to receive £13.1 million to drive antibiotic development
Monday 6 July 2009
Novacta Biosystems Ltd, which is developing a class of naturally-derived antibiotics, will receive up to £13.1 million in equity financing for the development of its portfolio, provided certain undisclosed milestones are met.
Location
United Kingdom
Elan completes $1.5 billion deal with Johnson & Johnson
Friday 3 July 2009
Elan Corporation Plc has reached an agreement with Johnson & Johnson that will give the US multinational an 18.4% stake in the company as well as controlling interest in a new unit that will hold many of Elan’s assets in Alzheimer’s disease.
Location
Ireland
UK to invest £150 million to stimulate venture funding of start-ups
Tuesday 30 June 2009
The UK government plans to invest £150 million in a small number of specialist technology funds, including those in the life sciences, in order to stimulate private venture capital funding of small businesses with a high-growth potential.
Location
United Kingdom
Wellcome Trust grants £4.3 million for asthma research
Tuesday 30 June 2009
The Wellcome Trust has awarded £4.3 million to researchers at St George’s, University of London to investigate a new class of drugs for asthma and allergies.
Location
United Kingdom
Clavis obtains funding for its lipid-based programme
Friday 26 June 2009
Clavis Pharma ASA, a Norwegian company that specialises in lipid-based delivery of pharmaceutical agents, achieved an endorsement of its technology with a placement of new shares worth NOK 129 million (€14.3 million).
Location
Norway
Lumavita tops up its Series A funding with CHF 6 million
Friday 19 June 2009
The Swiss specialty biopharmaceutical company, Lumavita AG, has topped up a recent Series A funding round with CHF 6 million, bringing the total amount raised for commercialising its lead antibiotic product to CHF 24 million.
Location
Switzerland
Pharming expands its equity position
Wednesday 17 June 2009
Pharming Group NV has expanded its equity by negotiating the conversion of some of its convertible debt into shares and by issuing about one million new shares from a stand-by equity facility.
Location
Netherlands
Allergy Therapeutics proposes a £22.4 million in share placement
Sunday 14 June 2009
Allergy Therapeutics Plc is proposing to raise up to £22.4 million in a private share placement which would give a group of South American investors up to 49.65% of the group’s enlarged share capital.
Location
United Kingdom
Gloom lifts in London as Proximagen raises £50 million
Monday 8 June 2009
A British medical discovery company with 25 employees, a history of losses and no products under clinical development is about to raise £50 million through a share sale on Britain’s junior stock market
Location
United Kingdom
Exiqon-led consortium gets funding for cancer test from a blood sample
Monday 25 May 2009
A consortium led by Exiqon A/S of Denmark has been awarded a DKK 24 million ($4.5 million) grant from the Danish National Advanced Technology Foundation to develop a new diagnostic to detect colon cancer from a blood sample.
Location
Denmark
Select a News Category
Recent Appointments
Pascale Witz to head strategic development at Sanofi
Monday May 6 2013
Srinivas Akkaraju joins Sofinnova Ventures
Monday May 6 2013
Vicente Anido nominated to Nicox board
Monday May 6 2013
Jeremy Farrar named director of the Wellcome Trust
Monday May 6 2013
Harry Kirsch becomes CFO at Novartis
Monday May 6 2013